Cyclin-dependent kinase inhibitor p21, via its C-terminal domain, is essential for resolution of murine inflammatory arthritis - Wikidata - awgldk - TriplyDB

Cyclin-dependent kinase inhibitor p21, via its C-terminal domain, is essential for resolution of murine inflammatory arthritis

Cyclin-dependent kinase inhibitor p21, via its C-terminal domain, is essential for resolution of murine inflammatory arthritis

http://www.wikidata.org/entity/Q35658843

about

Toll-like receptor-mediated IRE1α activation as a therapeutic target for inflammatory arthritis Distinct p21 requirements for regulating normal and self-reactive T cells through IFN-γ production.Activated protein C inhibits proliferation and tumor necrosis factor α-stimulated activation of p38, c-Jun NH2-terminal kinase (JNK) and Akt in rheumatoid synovial fibroblasts P21 deficiency delays regeneration of skeletal muscular tissue p21 deficiency is susceptible to osteoarthritis through STAT3 phosphorylation.Glycoprotein 96 perpetuates the persistent inflammation of rheumatoid arthritis Development of a new humanized mouse model to study acute inflammatory arthritis ApoE deficiency exacerbates the development and sustainment of a semi-chronic K/BxN serum transfer-induced arthritis model p21 mediates macrophage reprogramming through regulation of p50-p50 NF-κB and IFN-β The Role of IFN-β during the Course of Sepsis Progression and Its Therapeutic Potential.Cyclin-Dependent Kinase Inhibitor-1-Deficient Mice are Susceptible to Osteoarthritis Associated with Enhanced Inflammation.High-resolution magnetic resonance imaging of ankle joints in murine arthritis discriminates inflammation and bone destruction in a quantifiable manner.On How Fas Apoptosis-Independent Pathways Drive T Cell Hyperproliferation and Lymphadenopathy in lpr Mice.Modular bioinformatics analysis demonstrates that a Toll‑like receptor signaling pathway is involved in the regulation of macrophage polarization

P2860

Q28589300-A2C7482C-BA3C-4F33-AEB0-79FFD8B2A126 Q34877991-A6EE3F35-C740-42C3-907A-4DA417DB36AC Q35130879-686DA0C2-EBE7-4A6A-8C1C-DA997A0205A3 Q35571254-FDF52213-22D7-4C75-A1ED-BFB51F95F88C Q36259218-2A3728F3-59E7-46E3-9D84-D09026344D6E Q36322915-EBF5AFB3-1DE7-4498-BE06-F1F4E55C24B1 Q36346496-665546BB-A48E-4337-92F5-7CA646656F82 Q36991049-00821031-F80A-4FB7-B4CB-C4BB2C28ED1E Q37137884-E0F8CCBC-2A71-476D-8B64-630A883ED580 Q38769811-7E1A99AB-9029-4BF5-8104-C6381435F4AD Q38995523-AF2C1DF0-4B09-4A94-BEF8-C6779CFD65FB Q39010391-FDADCB1B-B883-476A-A288-DA96BCFD5CF7 Q41942913-5407F22E-FCF3-4604-B90A-63AD970C40BD Q57157340-C0C572DD-A70E-4687-94C1-B4BDE20995BA

P2860

Cyclin-dependent kinase inhibitor p21, via its C-terminal domain, is essential for resolution of murine inflammatory arthritis

http://www.wikidata.org/entity/Q35658843

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Cyclin-dependent kinase inhibi ...... murine inflammatory arthritis

@ast

Cyclin-dependent kinase inhibi ...... murine inflammatory arthritis

@en

type

label

Cyclin-dependent kinase inhibi ...... murine inflammatory arthritis

@ast

Cyclin-dependent kinase inhibi ...... murine inflammatory arthritis

@en

prefLabel

Cyclin-dependent kinase inhibi ...... murine inflammatory arthritis

@ast

Cyclin-dependent kinase inhibi ...... murine inflammatory arthritis

@en

P1433

Q35658843-7077275E-D1C5-4AD0-A688-7090606E5DAB

P1476

Q35658843-F245DC6A-647A-4339-A90B-5050F37D253C

P2093

Q35658843-01D45766-7A19-46ED-B16B-4E14C278834A

Q35658843-2ED00432-C888-43BF-A84F-0C025BBE8E00

Q35658843-47C2A858-93BF-4D8C-AEFE-D5997B00476D

Q35658843-4B8B2B75-1FC1-4C93-BC8F-D2306C636231

Q35658843-5AC84584-9183-443D-9166-27DA86A08262

Q35658843-634846A6-9FC4-40DE-A447-DB3994E5E4E4

Q35658843-7C85838A-A2A3-425C-8C5A-74D3473F00B8

Q35658843-8EB54F4E-9E4B-4331-B747-87A35FC27764

Q35658843-9215FFF0-5F6C-4557-8447-4850E45E9A80

Q35658843-D94FA559-D73A-4ED4-8F88-8CBFABDBE0D8

P2860

Q35658843-0593E0C5-1CBB-48EB-8C85-BADDD329F6E5

Q35658843-0607DB2F-1FC2-4F86-A2BD-8E9BB3AB9DC3

Q35658843-0BBF9633-3EF1-4E48-8409-704CF3B9A88E

Q35658843-0C3403F2-9792-4B43-946E-234F48C4CE0C

Q35658843-0DF1FFAA-0FE9-45EA-9EDB-2D3E49830BE4

Q35658843-1E45F20F-3895-4DE3-AECB-B037170D622B

Q35658843-28E59297-C4FA-4C40-B452-3F2022EE262D

Q35658843-2E3CB768-4394-4E28-877A-768A3515F1D3

Q35658843-2F48BF34-0EA4-4499-8613-58F8B70160F8

Q35658843-324F8241-36A3-47BB-85F7-1C9F3448C935

P304

Q35658843-8BA55F81-012C-4B6D-A792-91F343BC4DBD

P31

Q35658843-83BB14D8-C98C-47DB-847E-407E27201C3C

P356

Q35658843-0CDC3E30-1E18-42F4-8471-144C80E5EA7C

P433

Q35658843-02CB200A-4EF6-42E7-91C9-8FC68F5A28ED

P478

Q35658843-ECCA0F30-A6D1-475D-A2F7-2AAD3D8A08F2

P577

Q35658843-EA871B00-F45B-488A-A46F-B61C7726B7E0

P5875

Q35658843-94562412-45D2-4F01-8832-EAF9A93F49E1

P698

Q35658843-1C48D5A8-DCC0-40D4-AD85-026858D88AC1

P932

Q35658843-7C83832A-DEAF-47AA-A09A-3695D802E4CB

P356

P1433

Arthritis & Rheumatology

P1476

Cyclin-dependent kinase inhibi ...... murine inflammatory arthritis

@en

P2093

Alexander V Misharin

http://www.w3.org/2001/XMLSchema#string

Angelica K Gierut

http://www.w3.org/2001/XMLSchema#string

Carla M Cuda

http://www.w3.org/2001/XMLSchema#string

Deborah Veis Novack

http://www.w3.org/2001/XMLSchema#string

Dimitrios Balomenos

http://www.w3.org/2001/XMLSchema#string

Evan Weber

http://www.w3.org/2001/XMLSchema#string

G Kenneth Haines

http://www.w3.org/2001/XMLSchema#string

Harris Perlman

http://www.w3.org/2001/XMLSchema#string

Hemant Agrawal

http://www.w3.org/2001/XMLSchema#string

Melissa Mavers

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclin-binding motifs are essential for the function of p21CIP1

Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: chiral and sequence-specific effects on net cell uptake.

Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages.

BH3-only proteins in rheumatoid arthritis: potential targets for therapeutic intervention.

p21(WAF1/Cip1): more than a break to the cell cycle?

AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival.

Intracellular signal pathways: potential for therapies.

A regulatory SNP at position -899 in CDKN1A is associated with systemic lupus erythematosus and lupus nephritis.

p21Cip1 is required for the development of monocytes and their response to serum transfer-induced arthritis.

The role of chemokines in rheumatoid arthritis and osteoarthritis.

P304

141-152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.33311

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51625429

http://www.w3.org/2001/XMLSchema#string

P698

21898359

http://www.w3.org/2001/XMLSchema#string

P932

3253189

http://www.w3.org/2001/XMLSchema#string